Zacks: Peregrine Pharma – On the Verge of Releasing First Oncology Drug to Market

Peregrine Pharma (PPHM) recently announced that the US. Food and Drug Administration (FDA) has approved on the design for their Phase III registration trial for its oncology drug, Bavituximab.

Read more »